Mega Medipol-Hematology ( Site 0567)
Istanbul 34214
0 studies enrolling now · 1 studies all time
What they study most
Hematological Malignancies
Studies at this site
A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)
— Completed